|
|
|
Location: Home -
Products - Active Pharma Ingredients(API) - Antivirals
|
Raltegravir potassium
Catalogue No. : |
C14082 |
Product Name: |
Raltegravir potassium |
Synonym: |
MK 0518;Raltegravir Potassium Salt |
Chemical Name: |
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide potassium salt;Potassium 4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl- 2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan- 2-yl]-6-oxopyrimidin-5-olate |
CAS No. : |
871038-72-1 |
Structure : |
|
Molecular Formula: |
C20H20FKN6O5 |
Molecular Weight: |
482.51 |
Purity: |
>99% |
Usage: |
Raltegravir Potassium Salt is a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug. |
|
Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|